Drug – bio-affecting and body treating compositions – Identification or warning feature – Taste or smell or chemical irritation to the eye – nose – or...
Patent
1980-01-02
1981-04-14
Rose, Shep K.
Drug, bio-affecting and body treating compositions
Identification or warning feature
Taste or smell or chemical irritation to the eye, nose, or...
424 22, 424 35, 424253, A61K 922, A61K 936, A61K 3152
Patent
active
042619700
ABSTRACT:
A Theophylline sustained release granule comprises 10 to 45 wt. % of Theophylline, 30 to 60 wt. % of a metal salt of higher fatty acid and 0.5 to 10 wt. % of ethyl cellulose at a ratio of 1:1 to 1:3 by weight of Theophylline to said metal salt of higher fatty acid.
The Theophylline sustained release granule is effective for maintaining a suitable concentration of Theophylline in blood for a long time.
REFERENCES:
patent: 2928769 (1960-03-01), Gaunt
patent: 3062720 (1962-11-01), Costello
patent: 3079303 (1963-02-01), Raff et al.
patent: 3101293 (1963-08-01), Gaunt et al.
patent: 3102845 (1963-09-01), Fennell
patent: 3115441 (1963-12-01), Hermelin
patent: 3133863 (1964-05-01), Tansey
patent: 3136695 (1964-06-01), Tansey
patent: 3148124 (1964-09-01), Gaunt
patent: 3629393 (1971-12-01), Nakamoto et al.
patent: 3773920 (1973-11-01), Nakamoto et al.
Ogawa Keizaburo
Tanaka Satoru
Ukigaya Tadashi
Nikken Chemicals Co., Ltd.
Rose Shep K.
LandOfFree
Theophylline sustained release granule does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Theophylline sustained release granule, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Theophylline sustained release granule will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-158937